Clinical Trial

Methoxyflurane for Analgesia During Hysteroscopy

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 28, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is to assess the non-inferiority of using inhaled methoxyflurane (MOF) versus intravenous conscious sedation with fentanyl and midazolam on women's perception of pain, during hysteroscopy and/or polypectomy in an outpatient setting. The researchers will determine whether the participants receiving the inhaled MOF (experimental group) achieve similar clinical effects in reduction of pain and ability to complete the procedure. Women's perception of pain will be recorded on a scale from 0 to 10 using the numeric rating scale (NRS).
Trial Details
NCT Number NCT06899724
Lead Sponsor Dr. John A. Thiel Medical Professional Corporation
Conditions Analgesia
Enrollment 54 participants
Start Date 2025-06-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-28